M. Moik

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

R. Greil, W. Eiermann, M. Gnant, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients

R. Greil, R. Geisberger, C. Hufnagl, 2013 .

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

R. Greil, M. Gnant, H. Samonigg, 2013, British Journal of Cancer.

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

R. Greil, M. Gnant, P. Dubsky, 2018 .

A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

M. Stauch, H. Oettle, H. Riess, 2005 .

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).

C. Marosi, M. Preusser, D. Capper, 2014, Neuro-oncology.

Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme

R. Greil, B. Mlineritsch, C. Hauser-kronberger, 2007, Breast Cancer Research and Treatment.

Assessment of Chemotherapy-Induced Nausea and Vomiting in the Treatment of Gastrointestinal Tumors and Results of Secondary Prophylaxis with the Neurokinin-1-receptor Antagonist Aprepitant

T. Schuster, H. Lippert, S. Wolff, 2016 .

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

R. Greil, P. Steininger, D. Neureiter, 2019, Oncology letters.

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

R. Greil, B. Mlineritsch, R. Reitsamer, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer

R. Greil, M. Fridrik, B. Mlineritsch, 2009, Oncology Research and Treatment.

Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer

R. Greil, B. Mlineritsch, M. Moik, 2011, Oncology.

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs

R. Greil, T. Melchardt, A. Egle, 2014, BMC Complementary and Alternative Medicine.